ezetimibe has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brykner, R; Cwynar-Zając, Ł; Dzięgiel, P; Ewa Chlebda-Sieragowska, E; Fereniec-Gołębiewska, L; Gomułkiewicz, A; Kwiatkowska, J; Merwid-Ląd, A; Pieśniewska, M; Sozański, T; Szeląg, A; Szuba, A; Trocha, M | 1 |
| Nissen, SE; Taylor, AJ | 1 |
2 other study(ies) available for ezetimibe and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Topics: Amidohydrolases; Animals; Anticholesteremic Agents; Arginine; Azetidines; Ezetimibe; Liver; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reperfusion Injury; RNA, Messenger; Time Factors | 2013 |
Preliminary observations from preliminary trial results: have we finally had enough?
Topics: Adult; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cardiovascular Surgical Procedures; Ezetimibe; Heart Failure; Humans; Incidence; Neoplasms; Randomized Controlled Trials as Topic; Reperfusion Injury; Research Design; Simvastatin; Survival Analysis; Treatment Outcome | 2008 |